VNRX — VolitionRX Cashflow Statement
0.000.00%
Last trade - 00:00- $50.55m
- $34.67m
- $0.78m
Annual cashflow statement for VolitionRX, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -16.1 | -20.4 | -27 | -30.6 | -35.7 |
| Depreciation | |||||
| Non-Cash Items | 1.89 | 1.76 | 5.35 | 3.37 | 2.33 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.793 | 1.46 | -0.156 | 11 | 14.1 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -12.7 | -16.5 | -20.9 | -15.3 | -18.1 |
| Capital Expenditures | -0.511 | -1.94 | -0.974 | -1.57 | -1.08 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | 0.293 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.511 | -1.65 | -0.974 | -1.57 | -1.08 |
| Financing Cash Flow Items | -0.039 | -0.229 | -0.178 | -0.226 | -0.226 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.9 | 20.6 | 22.9 | 6.94 | 29 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.54 | 2.48 | 1.14 | -9.71 | 9.86 |